On October 21, data presented at the European Society for Medical Oncology (ESMO) congress highlighted results from the STAMPEDE trial...
Read More...
The post ESMO data highlights fastest-growing prostate cancer patient segment appeared first on Pharmaceutical Technology.
Original Article: ESMO data highlights fastest-growing prostate cancer patient segment